Clinical Trial Update: tDCS to Increase Aerobic Performance in Runners [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/Phase 2 clinical trial evaluating transcranial direct current stimulation (tDCS) to enhance aerobic performance in runners has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Athletic Performance

Drugs mentioned

• tDCS (transcranial direct current stimulation)

Snippet

Sponsor: University of Liege | Conditions: Athletic Performance | Phase 1, Phase 2 | Status: COMPLETED